UBS Maintains Neutral on Pediatrix Medical Group, Raises Price Target to $16.5
Benzinga Newsdesk 1 year ago
NewsPrice TargetAnalyst Ratings
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16 to $16.5.
UBS analyst A.J. Rice maintains Pediatrix Medical Group (NYSE:MD) with a Neutral and raises the price target from $16 to $16.5.